Data found reduced cardiovascular risk with hormone therapy, particularly among Black women and those starting treatment within 10 years of menopause.
News|Expert Interviews|August 14, 2020
CV Health: Risk Prevention, Challenges, Education
A key opinion leader discusses effective risk prevention measures and challenges to reducing adverse events. He also considers effective educational resources for self-care.
Advertisement
Advertisement
Related to this article
The update adds efficacy and safety data on adults newly diagnosed with pulmonary arterial hypertension.
Advertisement
Advertisement
Trending on Drug Topics
1
Muscle Preservation Is Key in GLP-1 Therapy for Postmenopausal Women
2
How the Main Street Pharmacy Access Act Advances Pharmacist Provider Status
3
Menopause Status, Symptoms Remain Inconsistently Documented
4
Pharmacy Law Lowdown: FDA’s Evaluation of Peptides
5